The Asthma Control Rate Achieved by Budesonide/Formoterol in Clinical Practice in China
Phase of Trial: Phase IV
Latest Information Update: 01 Jun 2017
At a glance
- Drugs Budesonide/formoterol (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 01 Jun 2017 Results published in the Respiratory Medicine
- 12 Oct 2014 Status changed from recruiting to completed reported by ClinicalTrials.gov.
- 10 Sep 2014 Planned End Date changed from 1 Aug 2014 to 1 Sep 2014 reported by ClinicalTrials.gov.